PVLA
Palvella Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$157.24
+1.14%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.86x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 3.75x
Liquidity & coverage
- Current ratio
- 21.18x
- Quick ratio
- 21.18x
- Cash ratio
- 20.97x
- Interest coverage
- -7.60x
- EBITDA / interest
- -6.58x
- Working capital
- $241.1M
Cash & dividend
- FCF / debt
- -68.25x
- Cash flow / debt
- -68.25x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026